Session » Systemic Sclerosis and Related Disorders – Clinical Poster I
- 9:00AM-11:00AM
-
Abstract Number: 797
Absolute Reduction of Peripheral CD4+ Regulatory T Cells in Patients with Systemic Sclerosis and Its Restoration By Short-Term and Low Dose IL-2 Treatment
- 9:00AM-11:00AM
-
Abstract Number: 800
Assessment of Recent Evidence to Support Treatment Recommendations in Patients with SSc-ILD
- 9:00AM-11:00AM
-
Abstract Number: 801
Cardiac Autonomic Modulation at Rest and during Orthostatic Stress in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 788
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 793
Clinical Associations of Anti-U11/U12 (RNPC-3) Autoantibodies in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 786
Comparison of Nailfold Microvascular Damage in Mixed Connective Tissue Disease Versus Systemic Sclerosis Patients during a Three Year Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 796
Demographic and Clinical Features of Systemic Sclerosis Patients with Anti-U1RNP Antibodies: A European Scleroderma Trials and Research (EUSTAR) Analysis
- 9:00AM-11:00AM
-
Abstract Number: 805
Diastolic Dysfunction in Scleroderma: An Investigation into Associated Risk Factors and Impact on Survival
- 9:00AM-11:00AM
-
Abstract Number: 806
Estradiol Levels Are Elevated in Older Men with Diffuse Cutaneous SSc and Are Associated with Decreased Survival
- 9:00AM-11:00AM
-
Abstract Number: 792
Evaluation of Esophageal Dysmotility in Systemic Sclerosis: Clinical VALUE of Computed Tomography
- 9:00AM-11:00AM
-
Abstract Number: 795
Frequency and Clinical Associations of Rare Antibodies in a Large Connective Tissue Disease Cohort
- 9:00AM-11:00AM
-
Abstract Number: 790
Gastrointestinal Symptom Burden and Quality of Life in Systemic Sclerosis: Understanding the Role of Diet
- 9:00AM-11:00AM
-
Abstract Number: 794
Identification of an Immunodominant Epitope on Rnpc-3 As a Target of Autoantibodies in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 811
Identification of Risk Factors for Gastric Antral Vascular Ectasia (GAVE) Among Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 812
Inflammatory Stays Inflammatory: A Subgroup of Systemic Sclerosis Characterized By High Morbidity and Inflammatory Resistance to Cyclophosphamide
- 9:00AM-11:00AM
-
Abstract Number: 787
Longitudinal Follow-up of Anti-Topoisomerase I Positive Patients within the Leiden Systemic Sclerosis Cohort – Prognosis Infaust?
- 9:00AM-11:00AM
-
Abstract Number: 808
Mean Number of Nailfold Capillaries Is Associated with Disease Activity at 6 Months Follow-up in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 814
NON Diffuse SSc, Peripheral Neuropathy, Concomitant Sjogren Syndrome and ANTI-RNA Polymerase III Represent Risk Factors for the Higher Frequency of Cancer in a Large Single Cohort of Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 798
Predominant Fasciitis and Mild Intramuscular Edema on Muscle Magnetic Resonance Imaging in Scleroderma-Associated Myopathy
- 9:00AM-11:00AM
-
Abstract Number: 804
Prevalence of Echocardiographic Abnormalities in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 813
Prevalence of Gastroesophageal Disease in Systemic Sclerosis and Its Impact on Lung Disease: Fact or Fiction
- 9:00AM-11:00AM
-
Abstract Number: 802
Prognostic Significance of Bicaudal D2 Antibodies in Sistemic Sclerosis (SSc) Patients
- 9:00AM-11:00AM
-
Abstract Number: 799
Progressive Lung Fibrosis in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease in the Eustar Database
- 9:00AM-11:00AM
-
Abstract Number: 791
Safety and Suitability of a Direct Thrombin Inhibitor, Dabigatran Etexilate, in Scleroderma-Associated Interstitial Lung Disease (SSc-ILD) Patients
- 9:00AM-11:00AM
-
Abstract Number: 810
Sexual Dysfunction in Women with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 807
The Effects of DNA Methylation on Differential Expression in Dermal Fibroblasts from African-American Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 809
The Lymphangiogenetic Factors VEGF-C, CCL21 and Ang-2 Are Associated with Pulmonary Arterial Hypertension in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 789
The Relationship between YKL-40 and Vascular Endothelial Growth Factor in Angiogenesis in Systemic Sclerosis Patients